Literature DB >> 22960076

Spontaneous latency in a rabbit model of pulmonary tuberculosis.

Selvakumar Subbian1, Liana Tsenova, Paul O'Brien, Guibin Yang, Nicole L Kushner, Sven Parsons, Blas Peixoto, Dorothy Fallows, Gilla Kaplan.   

Abstract

Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), is an exquisitely adapted human pathogen capable of surviving for decades in the lungs of immune-competent individuals in the absence of disease. The World Health Organization estimates that 2 billion people have latent TB infection (LTBI), defined by a positive immunological response to Mtb antigens, with no clinical signs of disease. A better understanding of host and pathogen determinants of LTBI and subsequent reactivation would benefit TB control efforts. Animal models of LTBI have been hampered generally by an inability to achieve complete bacillary clearance. Herein, we have characterized a rabbit model of LTBI in which, similar to most humans, complete clearance of pulmonary Mtb infection and pathological characteristics occurs spontaneously. The evidence that Mtb-CDC1551-infected rabbits achieve LTBI, rather than sterilization, is based on the ability of the bacilli to be reactivated after immune suppression. These rabbits showed early activation of T cells and macrophages and an early peak in the TNFα level, which decreased in association with clearance of bacilli from the lungs. In the absence of sustained tumor necrosis factor-α production, no necrosis was seen in the evolving lung granulomas. In addition, bacillary control was associated with down-regulation of several metalloprotease genes and an absence of lung fibrosis. This model will be used to characterize molecular markers of protective immunity and reactivation.
Copyright © 2012 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22960076      PMCID: PMC3483799          DOI: 10.1016/j.ajpath.2012.07.019

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  72 in total

1.  Strain-dependent CNS dissemination in guinea pigs after Mycobacterium tuberculosis aerosol challenge.

Authors:  Nicholas A Be; Lee G Klinkenberg; William R Bishai; Petros C Karakousis; Sanjay K Jain
Journal:  Tuberculosis (Edinb)       Date:  2011-08-09       Impact factor: 3.131

Review 2.  Immunological protection against tuberculosis.

Authors:  Willem A Hanekom; Brian Abel; Thomas J Scriba
Journal:  S Afr Med J       Date:  2007-10

3.  Virulence of Mycobacterium tuberculosis CDC1551 and H37Rv in rabbits evaluated by Lurie's pulmonary tubercle count method.

Authors:  W R Bishai; A M Dannenberg; N Parrish; R Ruiz; P Chen; B C Zook; W Johnson; J W Boles; M L Pitt
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 4.  TNF in host resistance to tuberculosis infection.

Authors:  Valerie F J Quesniaux; Muazzam Jacobs; Nasiema Allie; Sergei Grivennikov; Sergei A Nedospasov; Irene Garcia; Maria L Olleros; Yuriy Shebzukhov; Dmitry Kuprash; Virginie Vasseur; Stephanie Rose; Nathalie Court; Rachel Vacher; Bernhard Ryffel
Journal:  Curr Dir Autoimmun       Date:  2010-02-18

5.  Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology.

Authors:  Selvakumar Subbian; Liana Tsenova; Paul O'Brien; Guibin Yang; Mi-Sun Koo; Blas Peixoto; Dorothy Fallows; Jerome B Zeldis; George Muller; Gilla Kaplan
Journal:  Am J Pathol       Date:  2011-05-07       Impact factor: 4.307

Review 6.  Understanding latent tuberculosis: a moving target.

Authors:  Philana Ling Lin; Joanne L Flynn
Journal:  J Immunol       Date:  2010-07-01       Impact factor: 5.422

Review 7.  Initiation and regulation of T-cell responses in tuberculosis.

Authors:  K B Urdahl; S Shafiani; J D Ernst
Journal:  Mucosal Immunol       Date:  2011-03-30       Impact factor: 7.313

Review 8.  Letting sleeping dos lie: does dormancy play a role in tuberculosis?

Authors:  Michael C Chao; Eric J Rubin
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

Review 9.  Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response.

Authors:  Jacqueline M Achkar; Elizabeth R Jenny-Avital
Journal:  J Infect Dis       Date:  2011-11-15       Impact factor: 5.226

10.  The Mycobacterium marinum mel2 locus displays similarity to bacterial bioluminescence systems and plays a role in defense against reactive oxygen and nitrogen species.

Authors:  Selvakumar Subbian; Parmod K Mehta; Suat L G Cirillo; Jeffrey D Cirillo
Journal:  BMC Microbiol       Date:  2007-01-19       Impact factor: 3.605

View more
  31 in total

1.  Construction of an in vitro primary lung co-culture platform derived from New Zealand white rabbits.

Authors:  Joshua D Powell; Becky M Hess; Janine R Hutchison; Timothy M Straub
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-12-10       Impact factor: 2.416

Review 2.  Animal Models for Tuberculosis in Translational and Precision Medicine.

Authors:  Lingjun Zhan; Jun Tang; Mengmeng Sun; Chuan Qin
Journal:  Front Microbiol       Date:  2017-05-04       Impact factor: 5.640

3.  IL12B expression is sustained by a heterogenous population of myeloid lineages during tuberculosis.

Authors:  Allison E Reeme; Halli E Miller; Richard T Robinson
Journal:  Tuberculosis (Edinb)       Date:  2013-03-13       Impact factor: 3.131

4.  Detection of Mycobacterium tuberculosis in latently infected lungs by immunohistochemistry and confocal microscopy.

Authors:  Selvakumar Subbian; Eliseo Eugenin; Gilla Kaplan
Journal:  J Med Microbiol       Date:  2014-08-26       Impact factor: 2.472

Review 5.  Opening Pandora's Box: Mechanisms of Mycobacterium tuberculosis Resuscitation.

Authors:  Ashley V Veatch; Deepak Kaushal
Journal:  Trends Microbiol       Date:  2017-09-11       Impact factor: 17.079

Review 6.  The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells.

Authors:  Véronique Dartois
Journal:  Nat Rev Microbiol       Date:  2014-02-03       Impact factor: 60.633

Review 7.  Macrophages in tuberculosis: friend or foe.

Authors:  Evelyn Guirado; Larry S Schlesinger; Gilla Kaplan
Journal:  Semin Immunopathol       Date:  2013-07-18       Impact factor: 9.623

Review 8.  A medicinal chemists' guide to the unique difficulties of lead optimization for tuberculosis.

Authors:  Véronique Dartois; Clifton E Barry
Journal:  Bioorg Med Chem Lett       Date:  2013-07-12       Impact factor: 2.823

9.  Pharmacokinetics of rifapentine and rifampin in a rabbit model of tuberculosis and correlation with clinical trial data.

Authors:  Dalin Rifat; Brendan Prideaux; Radojka M Savic; Michael E Urbanowski; Teresa L Parsons; Brian Luna; Mark A Marzinke; Alvaro A Ordonez; Vincent P DeMarco; Sanjay K Jain; Veronique Dartois; William R Bishai; Kelly E Dooley
Journal:  Sci Transl Med       Date:  2018-04-04       Impact factor: 17.956

Review 10.  Rabbit Models for Studying Human Infectious Diseases.

Authors:  Xuwen Peng; John A Knouse; Krista M Hernon
Journal:  Comp Med       Date:  2015-12       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.